Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 382

1.

Hypoglycemia in patients with type 2 diabetes mellitus.

Miller CD, Phillips LS, Ziemer DC, Gallina DL, Cook CB, El-Kebbi IM.

Arch Intern Med. 2001 Jul 9;161(13):1653-9.

PMID:
11434798
2.

Association of younger age with poor glycemic control and obesity in urban african americans with type 2 diabetes.

El-Kebbi IM, Cook CB, Ziemer DC, Miller CD, Gallina DL, Phillips LS.

Arch Intern Med. 2003 Jan 13;163(1):69-75.

PMID:
12523919
3.

Comorbidity and glycemic control in patients with type 2 diabetes.

El-Kebbi IM, Ziemer DC, Cook CB, Miller CD, Gallina DL, Phillips LS.

Arch Intern Med. 2001 May 28;161(10):1295-300.

PMID:
11371257
5.

Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.

Ushakova O, Sokolovskaya V, Morozova A, Valeeva F, Zanozina O, Sazonova O, Zhadanova E, Starceva M, Kazakova E, Saifullina M, Shapiro I, Tarasov A, Al-Tayar B, Starkova N.

Clin Ther. 2007 Nov;29(11):2374-84.

PMID:
18158078
6.

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

Clin Ther. 2008 Aug;30(8):1448-60. doi: 10.1016/j.clinthera.2008.08.006. Erratum in: Clin Ther. 2008 Oct;30(10):1937.

PMID:
18803987
7.

PREDICTIVE- a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort.

Lüddeke HJ, Sreenan S, Aczel S, Maxeiner S, Yenigun M, Kozlovski P, Gydesen H, Dornhorst A; PREDICTIVE Study Group..

Diabetes Obes Metab. 2007 May;9(3):428-34.

PMID:
17391171
8.

Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: a meta-analysis.

Davidson JA, Liebl A, Christiansen JS, Fulcher G, Ligthelm RJ, Brown P, Gylvin T, Kawamori R.

Clin Ther. 2009 Aug;31(8):1641-51. doi: 10.1016/j.clinthera.2009.08.011.

PMID:
19808125
10.

Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

Ann Intern Med. 2008 Oct 21;149(8):531-9.

PMID:
18936501
11.
12.

Insulin lispro protamine suspension in intensive insulin treatment: an Italian observational study.

Citro G, Lorusso B, Rossi A, Romaniello M, Gentilella R, Cremasco F.

Curr Med Res Opin. 2009 Sep;25(9):2259-65. doi: 10.1185/03007990903166474.

PMID:
19630489
13.

Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.

Rosenstock J, Zinman B, Murphy LJ, Clement SC, Moore P, Bowering CK, Hendler R, Lan SP, Cefalu WT.

Ann Intern Med. 2005 Oct 18;143(8):549-58.

PMID:
16230721
14.

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.

Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG; GWAA Study Group..

Ann Intern Med. 2005 Oct 18;143(8):559-69.

PMID:
16230722
15.

Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.

Harris MI; National Health and Nutrition Examination Survey (NHANES III)..

Diabetes Care. 2001 Jun;24(6):979-82.

PMID:
11375356
16.

Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study.

Guerci B, Drouin P, Grangé V, Bougnères P, Fontaine P, Kerlan V, Passa P, Thivolet Ch, Vialettes B, Charbonnel B; ASIA Group..

Diabetes Metab. 2003 Dec;29(6):587-94.

PMID:
14707887
17.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
18.

Diabetes care, glycemic control, and complications in children with type 1 diabetes from Asia and the Western Pacific Region.

Craig ME, Jones TW, Silink M, Ping YJ.

J Diabetes Complications. 2007 Sep-Oct;21(5):280-7.

PMID:
17825751
19.
20.

Supplemental Content

Support Center